142 related articles for article (PubMed ID: 20437127)
1. Carboplatin and etoposide combined with radiotherapy for limited-stage small-cell esophageal carcinoma: three cases and review of the literature.
Isoyama Y; Shioyama Y; Nomoto S; Ohga S; Nonoshita T; Onishi K; Matsuura S; Atsumi K; Terashima K; Hirata H; Honda H
Jpn J Radiol; 2010 Apr; 28(3):181-7. PubMed ID: 20437127
[TBL] [Abstract][Full Text] [Related]
2. Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Gridelli C; Curcio C; Iaffaioli RV; Brancaccio L; D'Aprile M; Gebbia V; Rossi A; Tortoriello A; Veltri E; Maione P; Barbarisi A; Gallo C; Guida C; Perrone F
Anticancer Res; 2001; 21(6A):4179-83. PubMed ID: 11911315
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with cisplatin or carboplatin in combination with etoposide for small-cell esophageal cancer: a systemic analysis of case series.
Gao R; Zhang Y; Wen XP; Fu J; Zhang GJ
Dis Esophagus; 2014; 27(8):764-9. PubMed ID: 24118373
[TBL] [Abstract][Full Text] [Related]
4. [A case report of esophageal small cell carcinoma: a long-term survival by radio-chemotherapy with carboplatin and etoposide].
Watanabe S; Udagawa I; Ishida Y
Nihon Shokakibyo Gakkai Zasshi; 2004 Nov; 101(11):1217-20. PubMed ID: 15570870
[No Abstract] [Full Text] [Related]
5. [A case of primary small cell carcinoma of the esophagus responding remarkably to carboplatin (CBDCA) + etoposide (VP-16) combination therapy and radiation therapy].
Aizawa R; Takakura K; Kubo Y; Yoshizawa K; Kitahara T; Abe H; Matsuoka M; Aizawa Y; Tajiri H
Nihon Shokakibyo Gakkai Zasshi; 2009 Sep; 106(9):1334-42. PubMed ID: 19734705
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic impact of different chemotherapy strategies on small cell esophageal carcinoma].
Shen W; Deng W; Li N; Wei C; Luo S
Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):780-3. PubMed ID: 26813600
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.
Katada C; Komori S; Yoshida T; Kawakami S; Watanabe A; Ishido K; Azuma M; Wada T; Hosoda K; Yamashita K; Hiki N; Tanabe S; Ishiyama H; Koizumi W
Esophagus; 2020 Apr; 17(2):135-140. PubMed ID: 31321580
[TBL] [Abstract][Full Text] [Related]
8. [Combined alternating radiochemotherapy in stage III (TNM) (limited disease) small cell bronchial carcinoma: a phase II study with carboplatin/etoposide/vincristine and alternating radiotherapy].
Serke M; Riedel U; Schönfeld N; Pannhorst J; Förster B; Loddenkemper R
Pneumologie; 1999 Oct; 53(10):485-92. PubMed ID: 10596551
[TBL] [Abstract][Full Text] [Related]
9. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
Garst J; Herndon JE; Shafman T; Campagna L; Blackwell S; Padilla K; Bjurstrom T; Andrews C; Maravich-May D; Anderson E; Crawford J
Clin Drug Investig; 2006; 26(5):257-66. PubMed ID: 17163259
[TBL] [Abstract][Full Text] [Related]
11. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
[TBL] [Abstract][Full Text] [Related]
12. [Concurrent radiotherapy combined with carboplatin and etoposide in limited stage small cell lung cancer].
Qiao TK; Zhou DA; Xin L; Shu L; Wu W
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):237-9. PubMed ID: 15144613
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West Japan.
Katakami N; Takada M; Negoro S; Ota K; Fujita J; Furuse K; Ariyoshi Y; Ikegami H; Fukuoka M
Cancer; 1996 Jan; 77(1):63-70. PubMed ID: 8630941
[TBL] [Abstract][Full Text] [Related]
14. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
[TBL] [Abstract][Full Text] [Related]
15. Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Prendiville J; Radford J; Thatcher N; Steward W; Ranson M; Burt P; Stout R
J Clin Oncol; 1991 Aug; 9(8):1446-52. PubMed ID: 1649266
[TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
Skarlos DV; Samantas E; Kosmidis P; Fountzilas G; Angelidou M; Palamidas P; Mylonakis N; Provata A; Papadakis E; Klouvas G
Ann Oncol; 1994 Sep; 5(7):601-7. PubMed ID: 7993835
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
Edelman MJ; Chansky K; Gaspar LE; Leigh B; Weiss GR; Taylor SA; Crowley J; Livingston R; Gandara DR
J Clin Oncol; 2004 Jan; 22(1):127-32. PubMed ID: 14701775
[TBL] [Abstract][Full Text] [Related]
18. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Lange W; Mertelsmann R
Ann Oncol; 1999 May; 10(5):561-7. PubMed ID: 10416006
[TBL] [Abstract][Full Text] [Related]
19. Small cell carcinoma of the esophagus: a case report and review of the literature.
Jereczek-Fossa B; Airoldi M; Vasario E; Redda MG; Valente G; Orecchia R
Tumori; 2000; 86(2):174-7. PubMed ID: 10855859
[TBL] [Abstract][Full Text] [Related]
20. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
